These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29031613)

  • 1. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
    Majd H; King MS; Smith AC; Kunji ERS
    Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
    Pop A; Williams M; Struys EA; Monné M; Jansen EEW; De Grassi A; Kanhai WA; Scarcia P; Ojeda MRF; Porcelli V; van Dooren SJM; Lennertz P; Nota B; Abdenur JE; Coman D; Das AM; El-Gharbawy A; Nuoffer JM; Polic B; Santer R; Weinhold N; Zuccarelli B; Palmieri F; Palmieri L; Salomons GS
    J Inherit Metab Dis; 2018 Mar; 41(2):169-180. PubMed ID: 29238895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
    Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
    J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
    Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
    Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
    Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
    Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mitochondrial carriers of the SLC25 family function as monomers exchanging substrates with a ping-pong kinetic mechanism.
    Cimadamore-Werthein C; King MS; Lacabanne D; Pyrihová E; Jaiquel Baron S; Kunji ER
    EMBO J; 2024 Aug; 43(16):3450-3465. PubMed ID: 38937634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial citrate carrier in Yarrowia lipolytica: Its identification, characterization and functional significance for the production of citric acid.
    Yuzbasheva EY; Agrimi G; Yuzbashev TV; Scarcia P; Vinogradova EB; Palmieri L; Shutov AV; Kosikhina IM; Palmieri F; Sineoky SP
    Metab Eng; 2019 Jul; 54():264-274. PubMed ID: 31071446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of human D-2-hydroxyglutarate dehydrogenase and two disease related variants reveals the molecular cause of D-2-hydroxyglutaric aciduria.
    Toplak M; Brunner J; Schmidt J; Macheroux P
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140255. PubMed ID: 31349060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Citrate Transporters CtpA and YhmA Are Required for Extracellular Citric Acid Accumulation and Contribute to Cytosolic Acetyl Coenzyme A Generation in Aspergillus luchuensis mut.
    Kadooka C; Izumitsu K; Onoue M; Okutsu K; Yoshizaki Y; Takamine K; Goto M; Tamaki H; Futagami T
    Appl Environ Microbiol; 2019 Apr; 85(8):. PubMed ID: 30737343
    [No Abstract]   [Full Text] [Related]  

  • 10. A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity.
    Morciano P; Carrisi C; Capobianco L; Mannini L; Burgio G; Cestra G; De Benedetto GE; Corona DF; Musio A; Cenci G
    Hum Mol Genet; 2009 Nov; 18(21):4180-8. PubMed ID: 19654186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
    Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
    BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.
    Edvardson S; Porcelli V; Jalas C; Soiferman D; Kellner Y; Shaag A; Korman SH; Pierri CL; Scarcia P; Fraenkel ND; Segel R; Schechter A; Frumkin A; Pines O; Saada A; Palmieri L; Elpeleg O
    J Med Genet; 2013 Apr; 50(4):240-5. PubMed ID: 23393310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
    Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
    Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
    Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
    Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
    Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
    Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
    Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestation of recessive combined D-2-, L-2-hydroxyglutaric aciduria in combination with 22q11.2 deletion syndrome.
    Eguchi M; Ozaki E; Yamauchi T; Ohta M; Higaki T; Masuda K; Imoto I; Ishii E; Eguchi-Ishimae M
    Am J Med Genet A; 2018 Feb; 176(2):351-358. PubMed ID: 29265763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein.
    Jiang L; Boufersaoui A; Yang C; Ko B; Rakheja D; Guevara G; Hu Z; DeBerardinis RJ
    Metab Eng; 2017 Sep; 43(Pt B):198-207. PubMed ID: 27856334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A
    Li H; Hurlburt AJ; Tennessen JM
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity.
    Aluvila S; Kotaria R; Sun J; Mayor JA; Walters DE; Harrison DHT; Kaplan RS
    J Biol Chem; 2010 Aug; 285(35):27314-27326. PubMed ID: 20551333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.